Emergence of an MDR Klebsiella pneumoniae ST231 producing OXA-232 and RmtF in Switzerland

J Antimicrob Chemother. 2018 Mar 1;73(3):821-823. doi: 10.1093/jac/dkx428.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Carbapenems / pharmacology
  • Drug Resistance, Multiple, Bacterial*
  • Humans
  • Klebsiella Infections / epidemiology*
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / genetics*
  • Klebsiella pneumoniae / isolation & purification*
  • Microbial Sensitivity Tests
  • Switzerland / epidemiology
  • Whole Genome Sequencing
  • beta-Lactamases / biosynthesis

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • beta-Lactamases